STATES GET A BIG DOSE OF DRUGMAKERS' CASH

Because the federal government makes most of the important regulatory and legislative decisions affecting prescription drugs, their manufacturers have concentrated considerable lobbying efforts -- and campaign contributions -- on Washington. The Washington Post (http://www.washingtonpost.com/wp-dyn/content/article/2006/04/05/AR2006040502148.html)